Most people understand depression as a condition of the mind — low mood, loss of interest, diminished energy. What receives far less attention is that depression is also a condition of the body, producing measurable physical symptoms including chronic headaches that can persist for months or years. At Ketamine Wellness Institute Jacksonville, we treat patients whose depression has not responded to standard care, and the physical symptom burden those patients carry is consistently one of the most disruptive parts of the condition they describe.
Depression Is a Neurobiological Condition, Not a Mood Category
The clinical picture of major depressive disorder extends well beyond sadness. Mayo Clinic describes the symptom profile of depression as including fatigue, changes in appetite and sleep, slowed movement and thinking, difficulty concentrating, and unexplained physical problems — headaches and back pain among them. These are not secondary complications of depression. They are direct products of the neurobiological dysregulation that depression involves.
The brain systems that regulate mood and the brain systems that regulate pain are not separate. The same neurotransmitters — primarily serotonin and norepinephrine — that influence emotional state also modulate how the brain processes and suppresses pain signals. In depression, these systems are dysregulated. The result is a diminished ability to suppress pain, which effectively lowers the threshold at which physical sensations register as painful. A person with active depression may experience headaches as more severe, more frequent, and more treatment-resistant than those same headaches would be in the absence of the underlying mood disorder.
This is why treating the headache without treating the depression often produces limited results. The pain is not incidental to the mood disorder — it is, in meaningful part, produced by it.
The Bidirectional Relationship Between Depression and Pain
Research documents a well-established bidirectional relationship between depression and chronic pain: each condition reliably worsens the other (National Library of Medicine). Depression amplifies pain perception while lowering pain tolerance. Chronic pain, in turn, is a significant independent risk factor for developing depression and for worsening depression that is already present. For patients who have been managing both persistent headaches and depressive symptoms simultaneously, this cycle tends to be self-reinforcing and difficult to interrupt.
The practical consequence of this relationship is that patients in this cycle are often partially treated at best. Pain management that does not address the underlying depression may produce only limited relief, while antidepressant treatment that is inadequate or poorly matched to the patient’s neurobiology may fail to reduce the physical symptom burden even when it produces some improvement in mood. A treatment that meaningfully reduces the neurobiological load of depression has the potential to interrupt both sides of this cycle.
Depression is also associated with impaired memory and cognitive function — the same neural dysregulation that produces pain amplification also affects processing, concentration, and recall (National Library of Medicine). For patients dealing with depressive headaches alongside cognitive difficulties, the combined functional impact is substantially greater than either symptom alone. To understand more about how depression affects the brain at a biological level, see our post on what depression does to your brain.
Why Standard Antidepressants Don’t Always Resolve Physical Symptoms
First-line depression treatment typically involves SSRIs (selective serotonin reuptake inhibitors) or SNRIs (serotonin-norepinephrine reuptake inhibitors) — medications that work by increasing the availability of serotonin, or of both serotonin and norepinephrine, in the brain. These medications are effective for many patients and do reduce physical symptoms of depression for some. For others, however, multiple antidepressant trials have not produced adequate relief — not in mood, and not in the physical symptoms that accompany the mood disorder.
When depression does not respond to two or more medication trials at appropriate doses and durations, it is clinically characterized as treatment-resistant depression. This is not an uncommon situation — a meaningful portion of people who seek depression treatment do not achieve adequate response through standard pharmacological approaches. For those patients, continuing to cycle through serotonin-targeted medications is unlikely to produce different results, because the driving neurobiological mechanisms may involve systems those medications do not directly address.
Research has demonstrated that ketamine — which works by blocking NMDA receptors (N-methyl-D-aspartate receptors, a specific class of glutamate receptors) in the brain’s glutamate system — can produce rapid antidepressant effects in patients who have not responded to conventional treatments (National Library of Medicine). The glutamate system is the brain’s primary excitatory neurotransmitter network, and NMDA receptor blockade triggers a cascade of neurobiological effects distinct from anything serotonin-targeted medications produce. For patients whose depression has not responded to serotonin-targeted treatment, this mechanistic difference is the core clinical rationale for exploring ketamine. Our About Ketamine page explains this mechanism in greater depth.
What We Offer at Ketamine Wellness Institute Jacksonville
Every patient who contacts us about IV ketamine infusion therapy begins with a complimentary consultation by phone or videoconference with our board-certified anesthesiologist. That conversation covers treatment history, current symptoms, prior medication trials, and any medical considerations relevant to candidacy. We do not recommend treatment before conducting that review, and we do not move forward with patients who have not yet given standard options a reasonable trial.
For appropriate candidates, our standard mental health infusion series consists of six IV ketamine infusions administered over two to three weeks. Each infusion runs approximately 60 minutes, with full appointments lasting about 90 minutes to allow for preparation and recovery. Every session is supervised directly by our board-certified physician, with continuous monitoring of blood pressure, pulse, and oxygen saturation throughout.
Infusions take place in private treatment rooms with massaging recliners and dimmable lighting. Patients may bring one family member or friend to stay with them during treatment. Mild temporary side effects — most commonly a sense of dissociation, mild drowsiness, or brief nausea — typically resolve quickly once the infusion ends. For patients with a history of nausea, we pre-medicate as needed.
After the initial series, most patients continue with periodic maintenance infusions to sustain their response. The frequency is determined by individual response, but every four to eight weeks is a common pattern. Results vary by individual, and we encourage patients to discuss all treatment options with their existing providers as well as with us before making any decisions. You can review our current pricing for the initial series and maintenance sessions on our website.
The Fear of Trying Something Different
One barrier we hear about consistently is uncertainty — specifically, the concern that exploring a treatment like ketamine means acknowledging that nothing else has worked, or that the situation is more serious than the patient wants to believe. We’d frame that differently. Seeking a mechanistically distinct treatment after standard options have fallen short is not an admission of defeat. It is a clinically informed decision made by a patient who understands their own treatment history.
We also hear concern about what an infusion experience involves. The short answer is that every infusion at our clinic takes place in a private, supervised, clinical setting. Our physician is present. Vitals are monitored continuously. Patients are not left alone. The experience is designed to be as calm and controlled as the clinical situation allows, and we answer questions about it directly during the consultation so that patients are not surprised by anything.
Frequently Asked Questions
Can depression cause headaches even if I don’t feel sad? Yes. Depression presents differently across individuals, and not every patient experiences it primarily as sadness. Physical symptoms — including headaches, fatigue, and body pain — can be prominent features of depression even when mood symptoms are less obvious. If you are experiencing unexplained physical symptoms alongside changes in sleep, appetite, concentration, or energy, discussing the full picture with a qualified provider is the appropriate step.
Why do my headaches get worse when my depression is worse? The brain systems that regulate mood and pain overlap significantly. When depression is more active, the neurobiological dysregulation that characterizes the condition intensifies, and with it the brain’s reduced ability to suppress pain signals. This is why headache severity and mood often track together — they share a common neurobiological source.
Is ketamine safe for patients who also take antidepressants? That depends on the specific medications involved and each patient’s medical history. Some patients continue existing medications alongside ketamine treatment; others adjust their regimen under medical supervision. This is among the questions we address during the consultation, and we do not make blanket recommendations about it. Discuss your current medications openly with our physician and with your prescribing provider before making any changes.
How is the pricing structured at your clinic? Our initial mental health series is $3,000 for six infusions, billed at $500 per infusion. Maintenance infusions after the initial series are $500 per session. The initial consultation is complimentary. We recommend contacting your insurance provider to ask about out-of-network mental health benefits, as coverage for ketamine infusion therapy varies by plan.
Key Takeaways
- Depression is a neurobiological condition that produces measurable physical symptoms, including chronic headaches, through shared neural pathways between mood and pain regulation.
- Depression and chronic pain have a well-established bidirectional relationship — each worsens the other — making comprehensive treatment of the underlying depression critical for addressing physical symptom burden.
- Depression also impairs memory and cognitive function, compounding its functional impact beyond mood and pain alone.
- IV ketamine infusion therapy works through the glutamate system by blocking NMDA receptors — a mechanistically distinct approach from serotonin-targeted antidepressants that may help patients who have not responded to standard care.
- Results vary by individual — a complimentary consultation with our board-certified physician is the right starting point before any treatment decision.
Depression that produces physical pain is not an exaggeration or a secondary complaint — it is a direct expression of the same neurobiological disruption that drives the mood disorder. If you have been managing both and finding that standard treatment has not resolved either adequately, a different approach may be worth a conversation. We offer a complimentary consultation by phone or videoconference at Ketamine Wellness Institute Jacksonville. Call us at (904) 747-8998 or schedule a consultation online today.
References
Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/depression/symptoms-causes/syc-20356007
National Library of Medicine. https://pmc.ncbi.nlm.nih.gov/articles/PMC5494581/
National Library of Medicine. https://www.nature.com/articles/s41398-021-01327-5
Medical Disclaimer
The information in this blog is provided for educational purposes only and does not constitute medical advice. IV ketamine infusion therapy should only be pursued under the supervision of a licensed medical provider familiar with your complete medical and psychiatric history. Individual results vary. Not all patients are appropriate candidates for ketamine infusion therapy, and a thorough screening process is required prior to treatment. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.